Evidence map›Paper›PMID 39609498›Full record

ArticleScientific reports2024

Epidemiologic study on prostate cancer in Sudanese men across African ethnic groups.

Dalia Ahmed, Elsadig Ahmed Adam Mohammed, Mohamed Elimam Mohamed Ahmed, Yassin Mohamed Osman Abdalla, Ibrahin Hadad, Alsmawal Awad Elimam, Yousif Abdelhameed Mohammed, Moawia Mohammed Ali Elhassan, Amar Mohamed Ismail, Asim Osman Abdoun and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Dalia AhmedDepartment of Histopathology and Cytology, Faculty of Medical Laboratory Science, Al-Neelain University, Khartoum, Sudan.
Elsadig Ahmed Adam MohammedDepartment of Histopathology and Cytology, Faculty of Medical Laboratory Science, National Ribat University, Khartoum, Sudan.
Mohamed Elimam Mohamed AhmedUrology Department, Faculty of Medicine, University of Gezira, Wad Medani, Sudan.
Yassin Mohamed Osman AbdallaUrology Department, Faculty of Medicine, University of Gezira, Wad Medani, Sudan.
Ibrahin HadadDepartment of Histopathology and Cytology, Medical Laboratory Unit, Omdurman Teaching Hospital, Omdurman, Sudan.
Alsmawal Awad ElimamDepartment of Histopathology and Cytology, Faculty of Medical Laboratory Science, Al-Neelain University, Khartoum, Sudan.
Yousif Abdelhameed MohammedClinical Chemistry Department, Faculty of Medical Laboratory Science, University of Gezira, Wad Medani, Sudan.
Moawia Mohammed Ali ElhassanOncology Department, National Cancer Institute, University of Gezira, Wad Medani, Sudan.
Amar Mohamed IsmailDepartment of Biochemistry and Molecular Biology, Faculty of Science and Technology, Al-Neelain University, Khartoum, Sudan.
Asim Osman AbdounDepartment of Microbiology, Faculty of Veterinary Medicine, University of Khartoum, Khartoum, Sudan.
Stefano Cacciatore *International Centre for Genetic Engineering and Biotechnology, Bioinformatics Unit, Cape Town, South Africa. stefano.cacciatore@icgeb.org.
Luiz Fernando Zerbini *Cancer Genomics, International Centre for Genetic Engineering and Biotechnology, Cape Town, South Africa. luiz.zerbini@icgeb.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study sought to investigate the demographic and clinical characteristics of Sudanese men diagnosed with prostate cancer (PCa) to highlight differences in diagnosis among the three major ethnolinguistic groups. A total of 532 patients with confirmed PCa diagnosis through biopsy were enrolled from six medical centers in Sudan. The majority of patients, comprising 84.2% (448/532), were diagnosed with advanced-stage disease, with a Grade group above 3. There were no discernible differences in PCa aggressiveness among the ethnolinguistic groups. However, higher levels of prostate-specific antigen (PSA) were observed in the Niger-Congo group, where 55.2% had PSA values exceeding 50 ng/ml. Patients from this group were also diagnosed at a younger age. In contrast, 90.5% of Afro-Asiatic patients are over 60 years old. Further analysis conducted within an age-matched subgroup of patients (n = 273) revealed a higher incidence of perineural invasion in the Afro-Asiatic group. This research represents the first investigation of PCa across different African ethnic groups and associates a higher incidence of perineural invasion with a specific ethnic group. While recent efforts have been made to establish African-relevant risk models to mitigate PCa health disparities, there remains a need for further investigation into genetically distinct populations within the African continent.

Indexed as

Prostatic NeoplasmsAgedBlack PeopleEpidemiologic StudiesEthnicityHumansMaleMiddle AgedNeoplasm GradingProstate-Specific AntigenSudanProstate-Specific AntigenAfro-AsiaticIncidenceNiger-CongoNilo-SaharanPerineural invasionProstate cancerSudan

Identifiers

PMID39609498
PMCPMC11605049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.